Skip to main content
logo
PYC Therapeutics Limited (ASX:PYC)
Australia flag Australia · Delayed Price · Currency is AUD
2.400
+0.155 (6.90%)
Sep 17, 2026, 4:10 PM AEST

PYC Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
2,3601,657755560191207
Market Cap Growth
233.08%119.41%34.90%192.66%-7.47%-58.06%
Enterprise Value
1,9131,537708536175165
Last Close Price
2.401.691.261.170.540.62

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-20.0020.0020.0020.0020.00
PS Ratio
90.8163.7532.1525.3812.1012.89
PB Ratio
3.402.394.446.916.735.14
P/TBV Ratio
3.422.404.567.338.145.92

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
73.6159.1530.1224.2911.1010.26

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.000.000.010.010.010.02
Net Debt / Equity Ratio
-0.64-0.64-0.89-0.81-0.54-0.70
Net Debt / EBITDA Ratio
7.907.902.881.730.672.06
Net Debt / FCF Ratio
9.929.922.891.690.611.27
Asset Turnover
0.060.060.170.340.380.31
Quick Ratio
33.4433.4414.389.323.798.93
Current Ratio
33.4833.4814.419.403.798.95
Return on Equity (ROE)
-10.14%-10.14%-40.64%-69.61%-68.05%-30.37%
Return on Assets (ROA)
-8.05%-8.05%-24.42%-37.83%-35.49%-17.29%
Return on Capital Employed (ROCE)
-8.30%-8.30%-31.40%-47.30%-81.50%-34.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-1.84%-2.61%-6.66%-6.74%-11.91%-6.71%
FCF Yield
-1.91%-2.72%-6.96%-6.95%-13.02%-10.72%
Buyback Yield / Dilution
-46.37%-46.37%-27.16%-22.59%-0.93%-2.89%